AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimifos M1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Berlincleve Pharmaceuticals Llp

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimifos M1 Tablet PR

Diabex Duo tablets are classified as antidiabetic agents, a dual-medication formulation for managing type 2 diabetes in adults. This medication aids in regulating blood glucose levels. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can elevate glucose levels, potentially leading to kidney complications, vision loss, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by symptoms like sweating, lightheadedness, headache, and trembling. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be limited due to its hypoglycemic effect. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and potential blood tests to assess blood cell counts and liver function are necessary.

Primary Ingredients of Glimifos M1 Tablet PR

The information is unavailable.

Uses of Glimifos M1 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimifos M1 Tablet PR:

Follow your physician's instructions or consult the product label for usage guidelines. Always take Glimifos M1 Tablet PR with a meal.

Common Side effects of Glimifos M1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimifos M1 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for usage guidance. Take Glimifos M1 Tablet PR with meals.

How Glimifos M1 Tablet PR works:

Glimifos M1 Tablet PR combines glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to produce more insulin, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing the liver's glucose output, slowing glucose uptake from the gut, and enhancing insulin responsiveness throughout the body.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glimifos M1 Tablet PR is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimifos M1 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Glimifos M1 Tablet PR. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if these conditions arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glimifos M1 Tablet PR; dosage modification may be necessary. Consult your physician for guidance. Glimifos M1 Tablet PR is contraindicated in patients with severe renal disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimifos M1 Tablet PR cautiously, potentially requiring a modified dosage. Consult your physician for guidance. A low initial dose is typically recommended for individuals with mild to moderate hepatic dysfunction; it's contraindicated in those with severe liver disease.

What if you forget to take Glimifos M1 Tablet PR :

Should you forget a Glimifos M1 Tablet PR dose, take it immediately if you remember. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimifos M1 Tablet PR

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimifos M1 Tablet PR

Maintain this medication within its original, sealed container. Store as directed on the packaging or label. Discard any leftover medicine. Prevent access by children, pets, and others.
Glimifos M1 Tablet PR use can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare adverse reaction is particularly risky for individuals with kidney impairment, the elderly, or those who consume significant alcohol. Symptoms such as muscle aches, weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia warrant immediate discontinuation of Glimifos M1 Tablet PR and prompt medical attention.
Glimifos M1 Tablet PR, a dual-agent formulation containing glimepiride and metformin, manages type 2 diabetes mellitus in adults. This medication enhances glycemic control when combined with a suitable diet and physical activity regimen. Glimepiride's action involves stimulating pancreatic insulin secretion, while metformin reduces hepatic glucose output and improves insulin responsiveness. This specific combination is unsuitable for type 1 diabetes management.
Glimifos M1 Tablet PR administration may result in frequent side effects such as low blood glucose, taste disturbances, queasiness, abdominal discomfort, loose stools, and cephalalgia. Rare, yet potentially severe, adverse reactions include lactic acidosis. Prolonged therapy may additionally cause a deficiency in vitamin B12.
Prolonged Glimifos M1 Tablet PR administration can indeed lead to Vitamin B12 deficiency. This medication disrupts Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications such as paresthesia in the extremities, weakness, urinary dysfunction, cognitive impairment, and gait instability. To mitigate these risks, supplemental Vitamin B12 intake, at least annually, has been proposed by some studies.
Glimifos M1 Tablet PR can indeed induce hypoglycemia, characterized by low blood sugar. Manifestations of this condition may encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The likelihood increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic agents. Consequently, consistent blood glucose monitoring is crucial. Readily available simple sugars, such as glucose tablets, honey, or fruit juice, should always be kept on hand.
Combining Glimifos M1 Tablet PR and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia). Alcohol consumption may also heighten the likelihood of lactic acidosis.
Glimifos M1 Tablet PR
52
MRP 63
17% off